Postoperative Pulmonary Complications Between Patients Undergoing Abdominal Surgery in Plateau and Plain Areas

November 10, 2021 updated by: Wuhan Union Hospital, China

Differences in Incidence and Risk Factors of Postoperative Pulmonary Complications Between Patients Undergoing Abdominal Surgery in Plateau and Plain Areas

This study aims to collect perioperative diagnosis and treatment information of patients undergoing abdominal surgery at plateau and plain areas , collect blood and others samples for laboratory testing when necessary, analyzing the data to clarify the incidence and risk factors of pulmonary complications in patients undergoing abdominal surgery at different altitudes, so as to reduce the risk of pulmonary complications and even death in clinical practice.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Anticipated)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Qingping Wu, Professor
  • Phone Number: 13971605283
  • Email: wqp1968@163.com

Study Locations

  • China
    • Hubei
      • Wuhan, Hubei, China, 430022
        • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients aged 18 years or older who planned elective abdominal surgery under general anesthesia

Description

Inclusion Criteria:

  1. ≥ 18 years old；
  2. scheduled for elective abdominal surgery under general anesthesia；
  3. ASAⅠ-Ⅲ

Exclusion Criteria:

  1. Patients and their family members refused to be enrolled；
  2. patients were unable to communicate because of language disorders such as dementia and hearing impairment；
  3. patients were admitted to ICU 48 hours before operation；
  4. preoperative diagnosis of ARDS, aspiration pneumonia, pulmonary embolism or pulmonary edema or other acute respiratory diseases；
  5. mechanical ventilation within one week before operation；
  6. death or discharge within 24 hours after operation；
  7. second operation due to postoperative complications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Patients with pulmonary complications following abdominal surgery
Patients without pulmonary complications following abdominal surgery

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
incidence and risk factors of pulmonary complications
Time Frame: 1 week after surgery
1 week after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
ventilation duration,length of stay in ICU and Hospital Stay and death
Time Frame: within the 30 days after surgery
within the 30 days after surgery
incidence of Major Extrapulmonary Complications
Time Frame: within the 30 days after surgery
within the 30 days after surgery
Biomarkers
Time Frame: 1 week after surgery
1 week after surgery
incidence and risk factors of various specific pulmonary complications
Time Frame: 1 week after surgery
1 week after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wuhan Union Hospital, China

Collaborators

Qinghai People's Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2021

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

September 1, 2022

Study Registration Dates

First Submitted

October 25, 2021

First Submitted That Met QC Criteria

November 10, 2021

First Posted (Actual)

November 23, 2021

Study Record Updates

Last Update Posted (Actual)

November 23, 2021

Last Update Submitted That Met QC Criteria

November 10, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PPC202108

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pulmonary Complications;Abdominal Surgery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe